Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
LUMO on Nasdaq
There are no Buy or Sell transactions made by Kevin M. Lalande since 12/23/2023
Holdings reported by Kevin M. Lalande for Lumos Pharma, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
0 |
$0 |
$1.89 |
Dec 12, 2024 |
By Sante Health Ventures II, LP |
|
|
| Common Stock |
0 |
$0 |
$1.89 |
Dec 12, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
0 |
|
|
Dec 12, 2024 |
Direct |
Common Stock |
|
Transactions reported by Kevin M. Lalande for Lumos Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.